Facebook Twitter Youtube
  • Home
  • Find an Article
    • Volume 30 – 2025 Articles
      • Number 4: JUL – AUG 2025
      • Number 3: MAY – JUN 2025
      • Number 2: MAR – APR 2025
      • Number 1: JAN – FEB 2025
    • Volume 29 – 2024 Articles
      • Number 6: NOV – DEC 2024
      • Number 5: SEP – OCT 2024
      • Number 4: JUL – AUG 2024
      • Number 3: MAY – JUN 2024
      • Number 2: MAR – APR 2024
      • Number 1: JAN – FEB 2024
    • Volume 28 – 2023 Articles
      • Number 6: NOV-DEC 2023
      • Number 5: SEP-OCT 2023
      • Number 4: JUL-AUG 2023
      • Number 3: MAY-JUN 2023
      • Number 2: MAR-APR 2023
      • Number 1: JAN-FEB 2023
    • Volume 27 – 2022 Articles
      • Number 6: NOV-DEC 2022
      • Number 5: SEP-OCT 2022
      • Number 4: JUL-AUG 2022
      • Number 3: MAY-JUN 2022
      • Number 2: MAR-APR 2022
      • Number 1: JAN-FEB 2022
    • Volume 26 – 2021 Articles
      • Number 6: NOV-DEC 2021
      • Number 5: SEP-OCT 2021
      • Number 4: JUL-AUG 2021
      • Number 3: MAY-JUN 2021
      • Number 2: MAR-APR 2021
      • Number 1: JAN-FEB 2021
    • Volume 25 – 2020 Articles
      • Number 5: NOV-DEC 2020
      • Number 4: SEP-OCT 2020
      • Special Edition – June 2020
      • Number 3: MAY-JUN 2020
      • Number 2: MAR-APR 2020
      • Number 1: JAN-FEB 2020
    • OLDER ARCHIVES
  • STL Editions
    • Dermatology
      • Dermatology Edition
      • STL Derm Supplement
    • Family Practice
    • Pharmacist
  • Conditions
    • Acne
    • Eczema
    • Psoriasis
    • Skin Cancer
    • Fungal Infections
    • Rosacea
    • Aging Skin
    • Cosmetic Dermatology
  • Contributors
  • Videos
  • Downloads
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Skin Therapy Letter Skin Therapy Letter
  • Home
  • Find an Article
    • Volume 30 – 2025 Articles
      • Number 4: JUL – AUG 2025
      • Number 3: MAY – JUN 2025
      • Number 2: MAR – APR 2025
      • Number 1: JAN – FEB 2025
    • Volume 29 – 2024 Articles
      • Number 6: NOV – DEC 2024
      • Number 5: SEP – OCT 2024
      • Number 4: JUL – AUG 2024
      • Number 3: MAY – JUN 2024
      • Number 2: MAR – APR 2024
      • Number 1: JAN – FEB 2024
    • Volume 28 – 2023 Articles
      • Number 6: NOV-DEC 2023
      • Number 5: SEP-OCT 2023
      • Number 4: JUL-AUG 2023
      • Number 3: MAY-JUN 2023
      • Number 2: MAR-APR 2023
      • Number 1: JAN-FEB 2023
    • Volume 27 – 2022 Articles
      • Number 6: NOV-DEC 2022
      • Number 5: SEP-OCT 2022
      • Number 4: JUL-AUG 2022
      • Number 3: MAY-JUN 2022
      • Number 2: MAR-APR 2022
      • Number 1: JAN-FEB 2022
    • Volume 26 – 2021 Articles
      • Number 6: NOV-DEC 2021
      • Number 5: SEP-OCT 2021
      • Number 4: JUL-AUG 2021
      • Number 3: MAY-JUN 2021
      • Number 2: MAR-APR 2021
      • Number 1: JAN-FEB 2021
    • Volume 25 – 2020 Articles
      • Number 5: NOV-DEC 2020
      • Number 4: SEP-OCT 2020
      • Special Edition – June 2020
      • Number 3: MAY-JUN 2020
      • Number 2: MAR-APR 2020
      • Number 1: JAN-FEB 2020
    • OLDER ARCHIVES
  • STL Editions
    • Dermatology
      • Dermatology Edition
      • STL Derm Supplement
    • Family Practice
    • Pharmacist
  • Conditions
    • Acne
    • Eczema
    • Psoriasis
    • Skin Cancer
    • Fungal Infections
    • Rosacea
    • Aging Skin
    • Cosmetic Dermatology
  • Contributors
  • Videos
  • Downloads
  • Supplement

Protected: What’s New in Pre-Aging Topical Modalities: The Clinical Efficacy of Acetyl Dipeptide-31 Amide

By
STL Supplements
-
August 28, 2025

This content is password protected. To view it please enter your password below:

  • STL Achives
  • antioxidants
  • inflammation
  • Lasers
  • nutrition
Facebook
Twitter
Pinterest
WhatsApp
Linkedin
    STL Supplements

    RELATED ARTICLESMORE FROM THIS ISSUE

    Psoriasis

    Real World Canadian Case Series: Use of Tildrakizumab for Moderate-to-Severe Psoriasis

    Atopic Dermatitis

    Real-World Insights from Atopic Dermatitis Patients Treated with Abrocitinib

    Supplement

    Casmo Prevention and Management of Four Common Cutaneous Toxicities Associated with Targeted Cancer Therapies: Papulopustular Eruption, Xerosis, Paronychia, and Hand-Foot Skin Reaction

    LATEST: VOL 30.4 Jul-Aug, 2025

    Lebrikizumab for Moderate-to-Severe Atopic Dermatitis

    Nanodermatology

    Update on Drugs & Devices: July-August 2025

    POPULAR

    Dosing for Accutane® (Isotretinoin) Treatment

    Isotretinoin (Accutane®) Side Effects And Treatment Of Side Effects

    Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion

    Platelet-Rich Plasma (PRP): Current Applications in Dermatology

    Skin and Diet: An Update on the Role of Dietary Change as a Treatment Strategy for Skin Disease

    NEWSLETTER: Sign up and get free PDFs

    Sign Up for our Newsletter!

    Advertisement

    • Facebook
    • X
    • Mail
    • Disclaimer
    • Privacy Policy
    • Medical Advisory
    © SkinTherapyLetter. All rights reserved.
    Exit mobile version